Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2023-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
$152.4m
reported value
-10.7% vs Q1 2023
12positions
98.3%in top 10
2 new
2 added
7 reduced
1 sold out
vs Q1 2023
Options: 0 call positions (— notional), 1 put positions ($28.1m notional) – listed below, not included above.
Holdings, Q2 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS IN ARWR | $30.6m20.09% | Reduced -160.0k |
| BLUEPRINT MEDICINES CORP BPMC | $28.4m18.62% | Reduced -173.8k |
| MERUS N V MRUS | $20.4m13.39% | Reduced -450.0k |
| REGENXBIO INC RGNX | $17.4m11.42% | Added +39.1k |
| ARVINAS INC ARVN | $15.5m10.16% | Reduced -5.0k |
| KYMERA THERAPEUTICS INC KYMR | $15.0m9.83% | Added +50.0k |
| SILENCE THERAPEUTICS PLC SLN | $7.2m4.74% | Unchanged |
| GENMAB A/S GMAB | $6.6m4.36% | Reduced -68.2k |
| ARGENX SE ARGX | $6.4m4.17% | Reduced -7.7k |
| OLEMA PHARMACEUTICALS INC OLMA | $2.3m1.48% | New |
| C4 THERAPEUTICS INC CCCC | $2.1m1.37% | New |
| PIERIS PHARMACEUTICALS INC COM | $546.7k0.36% | Reduced -1.2m |
Sold out since Q1 2023
| Security | Value then |
|---|---|
| UNIQURE NV QURE | $12.8m637.5k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| ISHARES TR IWM · Put | $28.1m150.0k shares | New |